Tag: Kalytera
September 28, 2018
Big News Roundup: Relay Medical To Commence Trading in United States as RYMDF; BriaCell Announces Positive Phase IIa Proof of Concept Data in Advanced Breast Cancer; Initiates Combination Study; Kalytera Announces Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
In case you missed it, here is this week's big news roundup in the Life Science sector.
September 28, 2018
Big News Roundup: The Flowr Corporation Goes Public on the TSXV; Cannvas Signs Letter of Intent with Advica Health; Pure Global Completes Initial Sales License Review and Launches Groundbreaking Medical Cannabis Research Study with Appletree Medical Group
In case you missed it, here is this week’s cannabis big news roundup.
May 4, 2018
Big News Roundup: Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease; Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis
In case you missed it, here is this week's big news roundup in the Life Science sector.
May 2, 2018
Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease
Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the U.S. Patent and Trademark Office ("USPTO") issued... May 1, 2018
Kalytera Reports 2017 Financial Results
Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today reported financial results for the year-ended December 31, 2017. (All...
April 30, 2018
Key Stock Catalysts in the FDA Drug Application Process
Pharmaceutical and biotech companies in the US must follow a standard process to advance a new drug candidate through nonclinical...
April 29, 2018